Market by Deployment Mode, Component, Product Type, End-user, and Country | Forecast 2021-2028
As
mentioned in Triton’s report, the Asia-Pacific clinical trial management market
is anticipated to showcase growth in its revenue at a CAGR of 11.90% during the
projected phase of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries examined in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
The
region’s market is experiencing robust growth due to several factors, such as
an enhanced healthcare sector, increased number of hospitals equipped with
high-tech medical facilities, rising research & development sector, and
surge in healthcare reforms. In China, the pharmaceutical industry’s growth,
along with the rising research activities in genomics, are predominantly
driving the studied market’s growth. Also, several organizations are
collaborating to accelerate the adoption of clinical trial management products,
thereby fueling the clinical trial management market on a growth path across
China.
On
the other hand, R&D is at the forefront of the pharmaceutical industry in
Japan, owing to the appeal of its medicine market, along with the strength of
local research institutions. Moreover, the country’s R&D sector experienced
massive growth after the establishment of the Japanese Agency for Medical
Research and Development. Further, the reduction in the time required to
evaluate new drugs for approval has encouraged several pharma manufacturers to
establish R&D centers while enhancing their investments. Hence, such
factors are likely to influence the demand for clinical trial management
products, in turn, augmenting the Japanese clinical trial management market’s growth.
Bioclinica
Inc is involved in offering integrated clinical life science solutions,
delivering powerful insight into clinical trial development worldwide. Its wide
product portfolio includes medical imaging, clinical trial management software,
drug safety solutions, trial supply management and optimization, clinical
adjudication, and others. Besides, it services over 500 pharmaceutical,
biotechnology, and device organizations, including renowned biopharma companies
and CROs, across various regions, including the Asia-Pacific.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
SCOPE
2.2. KEY
INSIGHTS
2.2.1. ENTERPRISE-BASED
CTM CONTRIBUTES A MAJOR SHARE IN PRODUCT TYPE SEGMENT
2.2.2. HEALTHCARE
PROVIDERS ARE RAPIDLY GROWING END-USERS IN THE MARKET
2.2.3. SOFTWARE
IS THE LARGEST COMPONENT IN THE CLINICAL TRIAL MANAGEMENT MARKET
2.2.4. CLOUD
MODEL OF DEPLOYMENT IS A PROMISING SEGMENT IN THE MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. INTENSITY
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. MARKET
DRIVERS
2.6.1. ALARMING
RISE IN CHRONIC DISEASES
2.6.2. SURGE
IN RESEARCH & DEVELOPMENT IN THE MEDICAL SECTOR
2.6.3. BENEFITS
OFFERED BY CTM SOFTWARE
2.7. MARKET
RESTRAINTS
2.7.1. CONCERN
REGARDING THE SECURITY OF CTM SYSTEMS
2.7.2. LACK
OF SKILLED WORKFORCE
2.7.3. HIGH
COST OF IMPLEMENTATION
2.8. MARKET
OPPORTUNITIES
2.8.1. GROWTH
IN CLINICAL TRIALS
2.8.2. OUTSOURCING
CLINICAL TRIALS FOR COST REDUCTION
2.9. KEY
STRATEGIC DEVELOPMENTS
2.9.1. MERGER
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.9.3. PARTNERSHIP,
CONTRACT/AGREEMENT, & COLLABORATION
2.10. IMPACT
OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT MARKET
3. ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY DEPLOYMENT MODE
3.1. WEB-BASED
DEPLOYMENT
3.2. ON-PREMISE
DEPLOYMENT
3.3. CLOUD-BASED
DEPLOYMENT
4. ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY COMPONENT
4.1. SOFTWARE
4.2. HARDWARE
4.3. SERVICES
5. ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY PRODUCT TYPE
5.1. ENTERPRISE-BASED
CTM
5.2. SITE-BASED
CTM
6. ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY END-USER
6.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
6.2. CLINICAL
RESEARCH ORGANIZATIONS
6.3. HEALTHCARE
PROVIDERS
7. CLINICAL
TRIAL MANAGEMENT MARKET – ASIA-PACIFIC
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH
KOREA
7.5. ASEAN
COUNTRIES
7.6. AUSTRALIA
& NEW ZEALAND
7.7. REST
OF ASIA-PACIFIC
8. COMPETITIVE
LANDSCAPE
8.1. MEDIDATA
SOLUTIONS INC
8.2. ARISGLOBAL
LLC
8.3. BIOCLINICA
INC
8.4. BIO-OPTRONICS
INC
8.5. ADVARRA
(FORTE RESEARCH SYSTEMS INC)
8.6. ORACLE
CORPORATION
8.7. IBM
CORPORATION
8.8. MEDNET
SOLUTIONS INC
8.9. PAREXEL
INTERNATIONAL CORPORATION
8.10. VEEVA
SYSTEMS INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2020 & 2028 (IN %)
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: MARKET
ATTRACTIVENESS INDEX
FIGURE 4: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 5: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 6: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 7: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028 (IN $
MILLION)
FIGURE 11: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL
COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2021-2028
(IN $ MILLION)
FIGURE 14: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028 (IN $
MILLION)
FIGURE 15: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 16: CHINA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 17: JAPAN
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 18: INDIA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 19: SOUTH KOREA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: ASEAN
COUNTRIES CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: AUSTRALIA
& NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: REST OF
ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)